Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Cash & Current Investments: 2022-2025

Historic Cash & Current Investments for NewGenIvf (NIVF) over the last 4 years, with Sep 2025 value amounting to $2,969.3 billion.

  • NewGenIvf's Cash & Current Investments was N/A to $2,969.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2,969.3 billion, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2024, which is 2594.33% up from last year.
  • NewGenIvf's Cash & Current Investments amounted to $2,969.3 billion in Q3 2025, which was up 184,605,256.00% from $1.6 million recorded in Q2 2025.
  • Over the past 5 years, NewGenIvf's Cash & Current Investments peaked at $2,969.3 billion during Q3 2025, and registered a low of $27,556 during Q4 2022.
  • For the 3-year period, NewGenIvf's Cash & Current Investments averaged around $742.3 billion, with its median value being $1.5 million (2024).
  • Its Cash & Current Investments has fluctuated over the past 5 years, first tumbled by 96.34% in 2023, then soared by 2,594.33% in 2024.
  • NewGenIvf's Cash & Current Investments (MRQ) stood at $27,556 in 2022, then skyrocketed by 96.34% to $54,104 in 2023, then surged by 2,594.33% to $1.5 million in 2024, then surged by 203,694,042.99% to $2,969.3 billion in 2025.
  • Its Cash & Current Investments stands at $2,969.3 billion for Q3 2025, versus $1.6 million for Q2 2025 and $1.5 million for Q4 2024.